CDK12 and neoplasm: Moreover, most of these CDK12 mutations were mutually exclusive with alterations to the breast cancer type 1 and 2 susceptibility proteins (BRCA1 and BRCA2), a tissue-specific tumor suppressor, and a well-recognized DNA repair pathway component.